Complications of diabetes trouble people much more than diabetes itself, so it's very important to construct related animal models for diagnosis, prevention, and treatment of disease. Ace Therapeutics can develop different animal models of diabetes complications and provide valuable preclinical tools in research and evaluation for new drugs in treating a series of diabetes complications.
Vasculopathy develops over time in the tissues and organs of patients with DM, commonly including the heart, brain, kidneys, retina, foot, and nerves. These changes give rise to their respective chronic complications. The most common chronic complications considered as related to diabetes include microvascular disease and macrovascular diseases. Extensive epidemiological studies have consistently demonstrated that the duration of diabetes is positively related to the development of complications. Besides, there are more disabilities and deaths due to the complications arising from diabetes than from diabetes itself.
Fig. 1. Secondary complications associated with T2DM. (Blahova J, et al., 2021)
Ace Therapeutics offers clients a comprehensive range of model development services for diabetic complications, including diabetic nephropathy, diabetic peripheral neuropathy, and other complications. Our models can be used for mechanistic studies, drug screening, and pharmacodynamic evaluation of diabetic complications. Our customized animal model development services meet the specific project needs of our clients.
To assist customers in evaluating the efficacy of drugs using animal models of diabetes complications, we provide comprehensive analytical services.
For more information on how we can tailor our services to your specific needs, don't hesitate to contact us. In partnership with Ace Therapeutics, access to innovative models and expert support powers the diabetes complications research.
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.